CSW INDUSTRIALS, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CSW INDUSTRIALS, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	287	326	350	386	419	626	758	793	878	1,083
Cost of revenue	159	178	189	209	235	370	440	442	485	629
Gross profit	129	148	161	177	185	256	318	351	393	454
Research and development							4.8	5.9	5.3	5.8
Selling, general and administrative	95.6	98.3	101	110	125	159	179	190	212	270
Operating income	32	49.7	60.4	65.9	59.2	97.4	139	159	181	169
Other non-operating income	2.82	0.91	2.44	-7.14	-5.97	-0.47	0.04	-5.92	-0.86	-0.74
Pre-tax income	32.2	48.2	61.4	57.4	50.9	91.5	126	140	180	146
Income tax	14.4	15.6	15.4	12.7	10.8	24.1	29.3	37.9	42.6	32.7
Income from continuing operations	17.8	32.7	46.1	44.7	40.1	67.3	96.6	103	137
Net income to minority interests				0	0	0.93	0.14	0.89	0.83	0.8
Net income	11.1	-11.9	45.6	45.7	40.1	66.4	96.4	102	137	112
EBITDA	45.8	64.6	74.3	80.5	81.9	134	174	197	223	184
EPS, basic	0.70	-0.76	2.96	3.04	2.67	4.21	6.22	6.54	8.41	6.73
EPS, diluted	0.70	-0.76	2.93	3.01	2.65	4.20	6.20	6.52	8.38	6.70
Shares, basic (weighted)	15.8	15.7	15.4	15	15	15.8	15.5	15.5	16.2	16.7
Shares, diluted (weighted)	15.8	15.7	15.5	15.2	15.1	15.8	15.5	15.6	16.3	16.7

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	23.1	11.7	26.7	18.3	10.1	16.6	18.5	22.2	226	33.8
Receivables	59.8	63.4	66.1	74.9	96.7	123	123	143	156	210
Inventory	43.7	43	51.4	58.6	103	150	162	151	195	310
Other current assets	6.72	7.08	7.03	3.07	9.68	1.39	1.07	0.94	1.46	3.62
Total current assets	147	128	151	150	219	300	323	331	593	589
Property, plant and equipment	56.8	54.5	53.6	57.2	82.6	87	88.2	92.8	93.4	108
Lease right-of-use assets				16.4	61.7	67.1	59.8	44.5	62.1	68.6
Goodwill	80.9	81.8	86.3	91.7	219	225	243	247	264	633
Intangible assets	59.3	53.1	50.5	46.2	283	301	319	319	358	900
Long-term investments								0	2.5	7.3
Other non-current assets	16	24	11	24.2	76	82.7	70.5	53.1	70.8	87.4
Total assets	398	341	353	374	880	995	1,043	1,043	1,379	2,317
Accounts payable	10.4	16.8	19	22	32.4	47.8	40.7	48.4	54.8	76.9
Accrued liabilities	22.4	23.5	29.4	36.6	49.7	69	67.4	67.4	92.4	116
Short-term debt	0.56	0.56	0.56	0.56	0.56	0.56	0	0	0	29.5
Total current liabilities	38.5	44.9	49.2	59.1	82.7	117	108	116	147	227
Long-term debt	72.6	23.5	30.9	10.3	242	252	253	166	0	840
Lease liabilities				15.2	56.7	63.3	55.6	39.9	58.1	61.9
Other non-current liabilities	13.4	4.72	6.11	21.1	138	140	137	125	138	179
Total liabilities	126	75.1	88.9	92.5	464	511	499	408	287	1,247
Total debt	73.2	24	31.5	10.9	242	253	253	166	872	767
Paid-in capital	38.7	42.7	46.6	48.3	105	113	123	137	501	520
Retained earnings	245	234	278	319	351	408	493	583	705	799
Treasury stock	-1.01	-3.25	-50	-75.4	-34.1	-46.4	-82.7	-95.6	-122	-258
Other comprehensive income	-10.4	-7.48	-10.7	-11.4	-6	-5.07	-8.41	-9.13	-12.1	-11.1
Shareholders' equity	272	266	267	280	415	469	526
Total equity	272	266	267	277	415	469	526	616	1,072	1,050
Total liabilities and equity	398	341	353	369	880	995	1,043	1,043	1,379	2,317

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	11.1	-11.9	45.6	45.7	40.1	67.3	96.6	103	137	113
Depreciation and amortization	13.8	14.9	13.8	14.6	22.7	36.4	35	38.3	42.2	15.9
Stock-based compensation	2.81	3.66	3.94	5.07	5.09
Deferred income tax	3.12	1.9	0.48	0.3	-1.21	-1.9	-6.2	-2.39	-6.56	-4.75
Change in receivables	-5.03	-2.7	-3.83	-8	-7.22	-26.7	1.11	-17.9	-9.12	-27.1
Change in inventory	0.21	0.99	-5.54	-1.65	-3.38	-49.4	-11.4	10.4	-35.7	-36.8
Cash from operations	39	43.2	59.7	69.9	66.3	69.1	121	164	168	150
Capital expenditures	-6.87	-5.53	-7.52	-11.4	-8.83	-15.7	-14	-16.6	-16.3	-17.3
Acquisitions	-28.2	0	-10.1	-11.8	-287	-35.9	-55.9	-29.8	-84.7	-1,021
Purchases of investments							0	0	-2.5	-4.8
Sales and maturities of investments	0	0.55	3.91	0	6.15	0	0	1.67	0	0
Cash from investing	-26	-4.55	-3.06	-20.4	-290	-51.5	-69.7	-42.5	-102	-1,043
Debt issued								0	0	600
Debt repaid								0	0	-7.5
Stock issued	2.17	0.33	0	0	1.33	1.33	0	0	347	0
Share buybacks	-1.01	-2.24	-46.7	-28.5	-10.5	-19.3	-39.1	-15.3	-27.7	-133
Dividends paid	0	0	0	-8.13	-8.08	-9.46	-10.6	-11.8	-14.6	-18
Cash from financing	-15.3	-51.5	-39.3	-57.2	214	-13	-49.3	-117	138	701
Exchange rate effect	-0.59	1.47	-2.43	-0.62	1.34	1.94	-0.61	-1.1	-0.5	-0.1
Net change in cash	-2.84	-11.4	14.9	-8.31	-8.25	6.53	1.84	3.7	204	-192
Free cash flow	32.2	37.6	52.2	58.5	57.4	53.4	108	148	152	132
Interest paid	2.62	2.12	1.3	1.17	1.88	4.96	12.5	12.3	4.79	20.9
Income taxes paid	9.79	9.67	2.89	8.87	14	20.5	47.5	39.3	50.9	46.4

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to September 30, 2026; growth uses fiscal years. Valuation uses the share price of $285.62 on November 10, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	42.1%	Gross profit / revenue.
Operating margin	16.9%	Operating income / revenue.
EBITDA margin	18.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	13.2%	Pre-tax income / revenue.
Net margin	10.2%	Net income / revenue.
FCF margin	14.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	15.8%	Cash from operations / revenue.
Effective tax rate	22.4%	Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)	5.5%	Net income / average total assets.
SG&A / revenue	24.0%	Selling, general and administrative expense / revenue.
Capex / revenue	1.7%	Capital expenditures / revenue.
D&A / revenue	1.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	23.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	12.6%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	20.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	15.3%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	12.5%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	19.7%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-7.0%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	6.6%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	23.3%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-17.5%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	2.0%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	17.6%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-18.0%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	5.1%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	22.8%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-20.0%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	2.6%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	20.4%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-11.1%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	7.2%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	17.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-13.0%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	7.2%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	18.2%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	68.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	30.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	21.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	2.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	2.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	2.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.35x	Current assets / current liabilities.
Quick ratio	0.97x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.14x	(Cash + short-term investments) / current liabilities.
Debt / assets	32.8%	Total debt / total assets.
Liabilities / assets	51.2%	Total liabilities / total assets.
Net debt	$727.4M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	3.17x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$353.8M	Current assets - current liabilities.
Goodwill and intangibles / assets	65.0%	(Goodwill + intangible assets) / total assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.54x	Revenue / average total assets.
Fixed asset turnover	11.6x	Revenue / average property, plant and equipment.
Inventory turnover	2.31x	Cost of revenue / average inventory.
Days inventory	158 days	365 x average inventory / cost of revenue.
Receivables turnover	5.83x	Revenue / average receivables.
Days sales outstanding	63 days	365 x average receivables / revenue.
Days payables	53 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	168 days	Days inventory + days sales outstanding - days payables.
FCF conversion	139.1%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	10.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$7.81	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$76.78	Revenue / diluted weighted shares.
FCF per share	$10.87	Free cash flow / diluted weighted shares.
Operating cash flow per share	$12.14	Cash from operations / diluted weighted shares.
Cash per share	$2.28	(Cash + short-term investments) / shares outstanding.
Payout ratio	14.7%	Dividends paid / net income, when net income is positive.
Dividends / FCF	10.6%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	83.9%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$4.65B	Share price x shares outstanding.
Enterprise value	$5.38B	Market cap + total debt - cash - short-term investments.
P/E	36.5x	Market cap / net income. Only when net income is positive.
P/S	3.71x	Market cap / revenue.
P/FCF	26.2x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	23.5x	Market cap / cash from operations, when positive.
EV/Sales	4.29x	Enterprise value / revenue.
EV/EBIT	25.4x	Enterprise value / operating income, when both are positive.
EV/EBITDA	23.5x	Enterprise value / EBITDA, when both are positive.
EV/FCF	30.3x	Enterprise value / free cash flow, when both are positive.
FCF yield	3.8%	Free cash flow / market cap.
Earnings yield	2.7%	Net income / market cap (the inverse of P/E).
Dividend yield	0.4%	Dividends paid over the period / market cap.
Shareholder yield	3.6%	(Dividends paid + share buybacks) / market cap.
PEG	13.9x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was CSW INDUSTRIALS, INC.'s revenue in fiscal 2026?

CSW INDUSTRIALS, INC. reported revenue of $1.08B for fiscal 2026, 23.3% higher than the year before.

Was CSW INDUSTRIALS, INC. profitable in fiscal 2026?

Yes. Net income was $112.0M, a net margin of 10.4%.

How much free cash flow did CSW INDUSTRIALS, INC. generate in fiscal 2026?

Cash from operations of $149.7M minus capital expenditures of $17.3M left free cash flow of $132.4M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CSW INDUSTRIALS, INC.